PHEBRA Trademark

Trademark Overview


On Thursday, July 19, 2018, a trademark application was filed for PHEBRA with the United States Patent and Trademark Office. The USPTO has given the PHEBRA trademark a serial number of 88044450. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, September 26, 2025. This trademark is owned by Phebra Pty Ltd. The PHEBRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of [ pain, cancer, infectious diseases, ] gastrointestinal diseases and conditions, [ skin conditions, respiratory conditions, ] neurological disorders, psychiatric disorders, genetic disorders, hormonal disorders, cardiovascular disorders, human ion imbalances; cardiovascular agents for medical purposes; medicines for human purposes, namely, medicines for the treatment of [ cancer, epilepsy and manic, ] depressive and psychotic states; medicinal preparations, namely, medicines for the treatment of [ cancer, epilepsy and manic, ] depressive and psychotic states; [ vitamin preparations; ] electrolyte solutions for medical use, namely, electrolyte replacement solutions [ ; vaccines; antidotes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; in-vivo diagnostic agents used to visualize and differentiate tissues in the body, or to monitor the functioning and patency of tissues and organs; injectable soluti...
phebra

General Information


Serial Number88044450
Word MarkPHEBRA
Filing DateThursday, July 19, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, September 26, 2025
Registration Number5817862
Registration DateTuesday, July 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of [ pain, cancer, infectious diseases, ] gastrointestinal diseases and conditions, [ skin conditions, respiratory conditions, ] neurological disorders, psychiatric disorders, genetic disorders, hormonal disorders, cardiovascular disorders, human ion imbalances; cardiovascular agents for medical purposes; medicines for human purposes, namely, medicines for the treatment of [ cancer, epilepsy and manic, ] depressive and psychotic states; medicinal preparations, namely, medicines for the treatment of [ cancer, epilepsy and manic, ] depressive and psychotic states; [ vitamin preparations; ] electrolyte solutions for medical use, namely, electrolyte replacement solutions [ ; vaccines; antidotes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; in-vivo diagnostic agents used to visualize and differentiate tissues in the body, or to monitor the functioning and patency of tissues and organs; injectable solutions for medical purposes, namely, sterile injectable dyes for in vivo human medical diagnostic procedures ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 24, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhebra Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNew South Wales 2066
AU

Party NamePhebra Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew Soith Wales 2066
AU

Party NamePhebra Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew Soith Wales 2066
AU

Trademark Events


Event DateEvent Description
Friday, November 9, 2018NON-FINAL ACTION WRITTEN
Monday, July 23, 2018NEW APPLICATION ENTERED
Tuesday, July 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 7, 2018ASSIGNED TO EXAMINER
Friday, November 9, 2018NON-FINAL ACTION E-MAILED
Friday, November 9, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 21, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 22, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Monday, March 14, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 14, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 5, 2019ASSIGNED TO LIE
Friday, April 5, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Monday, March 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 14, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 16, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, September 26, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 26, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 26, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED